Índice Bovespa

US Dollar vs BRL

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Champions Oncology Inc (CSBR)
Champions Oncology Inc (CSBR) Notícias

CSBR

Champions Oncology (CSBR)

Champions Oncology Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:CSBR

<< Anterior 1 2 3 4

Data	Hora	Fonte	Título	Código	Companhia
01/09/2009	09:55	PR Newswire (US)	Champions Biotechnology to Deploy its Technology to Guide Development of Oncology Therapeutic for Global Biotech Leader	NASDAQ:CSBR
27/08/2009	17:26	PR Newswire (US)	Champions Biotechnology Reports Fiscal 2009 Full-Year Financial Results	NASDAQ:CSBR
16/07/2009	09:22	PR Newswire (US)	Champions Biotechnology Partners with Do-Coop Technologies to Advance Its Novel Oncology Compound Into Biomerk Tumorgraft(TM) Te	NASDAQ:CSBR
01/06/2009	09:52	PR Newswire (US)	Champions Biotechnology, Inc. Launches PersonalizedCancerTreatment.com	NASDAQ:CSBR
08/04/2009	09:22	PR Newswire (US)	Champions Biotechnology, Inc. Establishes UK Subsidiary and Retains General Manager to Expand Its Personalized Oncology Business	NASDAQ:CSBR
18/03/2009	09:22	PR Newswire (US)	Champions Biotechnology Reports Fiscal 2009 Third Quarter Financial Results	NASDAQ:CSBR
05/02/2009	11:22	PR Newswire (US)	Champions Biotechnology, Inc.'s Doug Burkett, PhD, to Present at BIO CEO & Investor Conference	NASDAQ:CSBR
30/07/2008	09:30	PR Newswire (US)	Champions Biotechnology Reports Fiscal 2008 Full-Year Financial Results	NASDAQ:CSBR
17/06/2008	09:00	PR Newswire (US)	Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate	NASDAQ:CSBR
07/05/2008	09:30	PR Newswire (US)	Champions Biotechnology and ImClone Systems Establish Agreement for Preclinical Evaluation of Oncology Drugs	NASDAQ:CSBR
06/05/2008	09:30	PR Newswire (US)	Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Dr	NASDAQ:CSBR
23/04/2008	10:30	PR Newswire (US)	Champions Biotechnology, Inc. Completes $2,500,000 Private Financing at $1.75 per Share	NASDAQ:CSBR
01/04/2008	09:00	PR Newswire (US)	Champions Biotechnology, Inc. Appoints New Board Members and Forms Management Team	NASDAQ:CSBR
06/03/2008	09:30	PR Newswire (US)	Champions Biotechnology, Inc. Reports Two Cents per Share Earnings for Three Quarters Ended January 31, 2008	NASDAQ:CSBR
23/10/2007	11:03	PR Newswire (US)	Dr. David Sidransky Appointed Chairman of Champions Biotechnology, Inc.	NASDAQ:CSBR
14/08/2007	09:03	PR Newswire (US)	Dr. David Sidransky Appointed Director of Champions Biotechnology, Inc.	NASDAQ:CSBR
11/06/2007	11:40	PR Newswire (US)	Dr. Manuel Hidalgo Appointed Director and Scientific Advisor of Champions Biotechnology, Inc.	NASDAQ:CSBR
21/05/2007	11:30	PR Newswire (US)	Champions Biotechnology, Inc. Acquires Biomerk, Inc.	NASDAQ:CSBR
14/02/2007	18:17	PR Newswire (US)	Champions Biotechnology, Inc. Acquires Rights to Cancer Drug Candidates	NASDAQ:CSBR
22/01/2007	13:33	PR Newswire (US)	Champions Sports, Inc. Changes Name to Champions Biotechnology, Inc.	NASDAQ:CSBR

Apresentando as notícias mais relevantes sobre:NASDAQ:CSBR

<< Anterior 1 2 3 4

Lampsa Hellenic Hotels

First Trust VI Multi Ass...

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições